Skip to main content
drug protocol number
CTD-TCNPC-301
drug sponsor
Cyclo Therapeutics, Inc
drug study
Hydroxypropyl-β-cyclodextrin (Trappsol® Cyclo™)
drug trial site
King Faisal Specialist Hospital and Research Center (Riyadh)
drug status
Ongoing
drug phase